Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Neuroprotective effect of rLosac on supplement-deprived mouse cultured cortical neurons involves maintenance of monocarboxylate transporter MCT2 protein levels.

Alvarez-Flores MP, H├ębert A, Gouelle C, Geller S, Chudzinski-Tavassi AM, Pellerin L.

J Neurochem. 2019 Jan;148(1):80-96. doi: 10.1111/jnc.14617. Epub 2018 Dec 3.

2.

Exploring the in vivo wound healing effects of a recombinant hemolin from the caterpillar Lonomia obliqua.

Sato AC, Bosch RV, Will SE, Alvarez-Flores MP, Goldfeder MB, Pasqualoto KF, da Silva BA, de Andrade SA, Chudzinski-Tavassi AM.

J Venom Anim Toxins Incl Trop Dis. 2016 Dec 21;22:36. doi: 10.1186/s40409-016-0093-4. eCollection 2016.

3.

Amblyomin-X having a Kunitz-type homologous domain, is a noncompetitive inhibitor of FXa and induces anticoagulation in vitro and in vivo.

Branco VG, Iqbal A, Alvarez-Flores MP, Sciani JM, de Andrade SA, Iwai LK, Serrano SM, Chudzinski-Tavassi AM.

Biochim Biophys Acta. 2016 Oct;1864(10):1428-35. doi: 10.1016/j.bbapap.2016.07.011. Epub 2016 Jul 30.

PMID:
27479486
4.

Hemolin triggers cell survival on fibroblasts in response to serum deprivation by inhibition of apoptosis.

Bosch RV, Alvarez-Flores MP, Maria DA, Chudzinski-Tavassi AM.

Biomed Pharmacother. 2016 Aug;82:537-46. doi: 10.1016/j.biopha.2016.05.043. Epub 2016 Jun 6.

PMID:
27470394
5.

Interaction of Leptospira interrogans with human proteolytic systems enhances dissemination through endothelial cells and protease levels.

Vieira ML, Alvarez-Flores MP, Kirchgatter K, Romero EC, Alves IJ, de Morais ZM, Vasconcellos SA, Chudzinski-Tavassi AM, Nascimento AL.

Infect Immun. 2013 May;81(5):1764-74. doi: 10.1128/IAI.00020-13. Epub 2013 Mar 11.

6.

The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas.

Seguin F, Carvalho MA, Bastos DC, Agostini M, Zecchin KG, Alvarez-Flores MP, Chudzinski-Tavassi AM, Coletta RD, Graner E.

Br J Cancer. 2012 Sep 4;107(6):977-87. doi: 10.1038/bjc.2012.355. Epub 2012 Aug 14.

7.

Functional characterisation of vizottin, the first factor Xa inhibitor purified from the leech Haementeria vizottoi.

Oliveira DG, Alvarez-Flores MP, Lopes AR, Chudzinski-Tavassi AM.

Thromb Haemost. 2012 Sep;108(3):570-8. doi: 10.1160/TH12-04-0235. Epub 2012 Jul 10.

PMID:
22782262
8.

Losac, the first hemolin that exhibits procogulant activity through selective factor X proteolytic activation.

Alvarez-Flores MP, Furlin D, Ramos OH, Balan A, Konno K, Chudzinski-Tavassi AM.

J Biol Chem. 2011 Mar 4;286(9):6918-28. doi: 10.1074/jbc.M110.167718. Epub 2010 Dec 22.

9.

New insight into the mechanism of Lonomia obliqua envenoming: toxin involvement and molecular approach.

Alvarez Flores MP, Zannin M, Chudzinski-Tavassi AM.

Pathophysiol Haemost Thromb. 2010;37(1):1-16. doi: 10.1159/000320067. Epub 2010 Aug 14. Review.

PMID:
20714126
10.

Exploring new molecules and activities from Lonomia obliqua caterpillars.

Chudzinski-Tavassi AM, Alvarez Flores MP.

Pathophysiol Haemost Thromb. 2005;34(4-5):228-33. Review. Erratum in: Pathophysiol Haemost Thromb. 2006;35(5):410.

11.

Losac, a factor X activator from Lonomia obliqua bristle extract: its role in the pathophysiological mechanisms and cell survival.

Alvarez Flores MP, Fritzen M, Reis CV, Chudzinski-Tavassi AM.

Biochem Biophys Res Commun. 2006 May 19;343(4):1216-23. Epub 2006 Mar 20.

PMID:
16597435

Supplemental Content

Loading ...
Support Center